pioneer 5 semaglutide Efficacy, safety and cardiovascular outcomes of once‐daily oral in patients with type 2 diabetes: The programme - Thethi - 2020 - Diabetes, Obesity and Metabolism SEMAGLUTIDE REDUCES HIGH-SENSITIVITY CRP LEVELS
Description
doi: 10.1016/j.bmc.2005.01.009
Mental health effects of GLP-1 receptor agonists
The guidelines now support exactly that approach
"Probiotics, prebiotics, synbiotics and insulin sensitivity"
It can be a huge help to see it done correctly
Disadvantages include no additional support for common GLP-1 side effects
